Patents by Inventor Steven Z. PAVLETIC

Steven Z. PAVLETIC has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NEUTROPHIL ELASTASE INHIBITORS FOR USE IN THE TREATMENT OF FIBROSIS
    Publication number: 20240382472
    Abstract: The invention relates to treatments for fibrosis by administering a neutrophil elastase inhibitor, such as alvelestat. In particular, the invention relates to treatments for fibrosis in combination with another disease, such as organ rejection, for example bronchiolitis obliterans syndrome optionally associated with graft-versus-host-disease.
    Type: Application
    Filed: October 20, 2022
    Publication date: November 21, 2024
    Applicants: MEREO BIOPHARMA 4 LIMITED, THE UNITED STATE OF AMERICA AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICE
    Inventors: Jacqueline PARKIN, Steven Z. PAVLETIC, Annie IM, Noa G. HOLTZMAN, Cody J. PEER
  • ALVELESTAT FOR USE IN THE TREATMENT OF GRAFT REJECTION, BRONCHIOLITIS OBLITERANS SYNDROME AND GRAFT VERSUS HOST DISEASE
    Publication number: 20220354833
    Abstract: The invention relates to treatments for organ rejection, in particular to treatments for lung transplant associated bronchiolitis obliterans syndrome by administering a neutrophil elastase inhibitor, such as alvelestat. The invention also relates to treatments for graft versus host disease.
    Type: Application
    Filed: September 17, 2020
    Publication date: November 10, 2022
    Applicants: MEREO BIOPHARMA 4 LIMITED, DUKE UNIVERSITY, NATIONAL CANCER INSTITUTE
    Inventors: Jacqueline PARKIN, Anthony SUNG, Steven Z. PAVLETIC, Annie IM, Noa G. HOLTZMAN, Cody J. PEER